U.S. stock night market volatility: FDA restarts review + rating upgrade, Capricor surges 58%Price Alert·Aug 16 at 08:46 PMCAPR-14.35%
Global pharma giants turn to Chinese biotech to tap innovation, valuation growthSCMP·Aug 9 at 04:55 AMAZN-0.28%010930.00%
China’s fast-changing consumers force MNCs to adapt via local alliancesSCMP·Jun 8 at 07:31 PMGIS-0.95%SBUX-0.94%
This week's largest increase in margin financing balance: KEBODA margin financing balance: 449 million yuan, balance increase: 161.46%; ZHENDE MEDICAL margin financing balance: 544 million yuan, balance increase: 124.55%Zhitong·Sep 21, 2025 at 07:20 AM6033010.00%6037860.00%
ZHENDE MEDICAL rose 6.90% today, with one institutional special seat net selling 102 million yuanZhitong·Sep 15, 2025 at 04:41 AM6033010.00%
ZHENDE MEDICAL's controlling shareholder and concerted parties plan to transfer 5% of the company's shares through an agreementZhitong·Sep 10, 2025 at 07:47 AM6033010.00%
Global Undiscovered Gems Featuring Shanghai Yaohua Pilkington Glass Group And Two Promising Small CapsSimplywall·Sep 9, 2025 at 04:58 AM6033010.00%
ZHENDE MEDICAL: Net profit of 128 million yuan in the first half of 2025, a year-on-year decrease of 20.70%Zhitong·Aug 27, 2025 at 04:40 AM6033010.00%
ZHENDE MEDICAL: Plans to repurchase 615,667 unvested shares of the companyZhitong·Jul 23, 2025 at 06:37 PM6033010.00%
ZHENDE MEDICAL: In the first quarter, the net profit attributable to the parent company was 51.2419 million yuan, a year-on-year decrease of 30.19%Zhitong·Apr 25, 2025 at 07:32 AM6033010.00%
ZHENDE MEDICAL issued a profit forecast, expecting a net profit of 373 million to 393 million yuan for the fiscal year 2024, an increase of 88% to 98.09% year-on-yearZhitong·Jan 21, 2025 at 03:01 AM6033010.00%
ZHENDE MEDICAL: Expected net profit growth of 88.00% to 98.09% year-on-year in 2024USHK News·Jan 21, 2025 at 02:43 AM6033010.00%
